International study reveals factors contributing to COVID-19 vaccine hesitancy among healthcare providers


Newswise—New York, May 31, 2022 – A new 23 countries study by a multidisciplinary team of researchers from the journal Vaccinepublished by Elsevier, sheds light on factors contributing to COVID-19 vaccine hesitancy among healthcare providers.

To assess associations between self-reported vaccine hesitancy and a number of sociodemographic and COVID-19 vaccine perception factors, CUNY Graduate School of Public Health and Health Policy (CUNY SPH) Principal Investigator Jeffrey Lazarus, PhD , Dean Ayman El-Mohandes, MBBCh, MD, MPH, FAAP, and colleagues from Dalhousie University School of Health Administration, Halifax, Canada and Barcelona Institute for Global Health, Barcelona, Spain, have developed a cross-sectional survey on perceptions of risk, efficacy, safety and confidence and current uptake of the COVID-19 vaccine.

The survey was administered to 23,000 adults in Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, UK and US in June 2021. Of those surveyed, 3,295 identified themselves as service providers. health care, such as doctors, nurses and community health workers.

Responses revealed that while most healthcare providers received one or more doses of a COVID-19 vaccine, a substantial minority reported hesitation. Four hundred ninety-four (15.0%) of participants said they would be reluctant to accept a COVID-19 vaccine, and 132 (4.0%) of them said they would refuse it outright.

Of the health care providers surveyed, physicians were the least hesitant. Vaccine hesitancy was more likely to occur among people with income below the median income and, to a lesser extent, younger people. Safety and risk concerns and lack of confidence in the equitable distribution of vaccines were strongly associated with hesitancy, less so than concerns about the effectiveness of COVID-19 vaccines.

Previous studies aimed to gauge the potential acceptance of a COVID-19 vaccine among healthcare providers, but few have been published since vaccines became widely available.

“These findings are troubling,” says Dean El-Mohandes. “Since healthcare worker hesitancy can negatively influence community perceptions, particularly among patients and family members, and may contribute to their refusal or delayed uptake of the COVID-19 vaccine. “

“Vaccine hesitancy can hamper the potential success of global vaccination campaigns and, therefore, our ability to control the COVID-19 pandemic,” says Dr. Lazarus. “Trainings and campaigns that reinforce vaccine safety, the dissemination of scientific data underpinning vaccine development, and clear, consistent and comprehensive information and commitment supporting the equitable distribution of vaccines are all potentially useful strategies to encourage hesitant healthcare professionals to get vaccinated. »

Notes for Editors
This article is “Factors Affecting COVID-19 Vaccination Hesitancy Among Health Care Providers in 23 Countries” by Jeanna Parsons Leigh, Stephana J. Moss, Trenton M. White, Camila A. Picchio, Kenneth H. Rabin, Scott C. Ratzan, Katarzyna Wyka, Ayman El-Mohandes, Jeffrey V. Lazare ( It appears as an article in the press in the newspaper Vaccinepublished by Elsevier.

Elsevier Novel Coronavirus Information Center provides expert-curated information for researchers, healthcare professionals and public health officials, including clinical guidance and a portal to access all of Elsevier’s research on COVID-19. All resources are available for free. We also have dedicated hubs for healthcare professionals; health educators and students; librarians; and R&D professionals. You can find them in our Directory of coronavirus resources.

The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) is committed to promoting and sustaining healthier populations in New York City and around the world through excellence in education, research, and service in public health and advocating for healthy policies and practices to advance social justice and improve health outcomes for all.

About Vaccine
Vaccine is the go-to journal for those interested in vaccines and immunization. It is the official journal of the Edward Jenner Society and the Japanese Society of Vaccinology and is published by Elsevier

About Elsevier
As a world leader in information and analysis, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating information and critical decision-making for customers in global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring the same rigor to our information analysis solutions for researchers, healthcare professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for over 140 years. Stemming from our publishing roots, we offer valuable insights and analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, Clinical Key and Sherpath strategic support research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our more than 2,700 digitized journals, including The Lancet and Cell; our more than 43,000 e-book titles; and our iconic reference books, such as Grey’s Anatomy. With the Elsevier Foundation and our external Inclusion and Diversity Advisory Councilwe work in partnership with various stakeholders to advance inclusion and diversity in science, research and health care in developing countries and around the world.

Elsevier is part of RELXa global provider of information-based analytics and decision-making tools for professionals and businesses.


Comments are closed.